236,
163 41, ΗΛΙΟΥΠΟΛΗ
/ FAX: 210-5201474 e-mail: possasdia@gmail.com possasdia@yahoo.gr possasdia@hotmail.com site: www.glikos-planitis.gr
facebook: "Γλυκός
e-mail: evichris_4@hotmail.com
ΠΡΟΕΔΡΟΣ:
ΑΝΤΙΠΡΟΕΔΡΟΣ Β’:
ΓΕΝΙΚΗ ΓΡΑΜΜΑΤΕΑΣ:
ΑΘΑΝΑΣΙΑ ΚΑΡΟΥΝΟΥ Σύλλογος Διαβητικών Ν. Μεσσηνίας «Γλυκιά Μεσσηνία»
ΑΝΑΠΛΗΡΩΤΡΙΑ ΓΕΝΙΚΗ ΓΡΑΜΜΑΤΕΑΣ:
ΒΑΣΙΛΙΚΗ ΠΑΠΑΡΟΥΝΑ Σύλλογος Διαβητικών ΠΕ Φθιώτιδας ΤΑΜΙΑΣ:
ΠΕΡΙΕΧΟΜΕΝΑ
Τ: 210 9589775 - F: 210 9589536 E: point@point.com.gr, U: www.printingpoint.gr
Ασκληπείου Βούλας ΚΩΝΣΤΑΝΤΙΝΙΔΗΣ ΚΩΝ/ΝΟΣ Χειρουργός Ουρολόγος Δ/ντής Ανδρολογικού Ινστιτούτου ΛΑΖΑΝΑ ΓΕΩΡΓΙΑ Ειδική Παθολόγος - Διαβητολόγος, Επιμελήτρια Πανεπιστημιακού Νοσοκομείου Πατρών. Συνεργάτης Heinrech - Heine Πανεπιστημίου Dusseldorf
Join us against diabetes
3.
4.
•
•
•
(HFrEF, HFmrEF, HFpEF)
American Diabetes Association, American Association of Clinical Endocrinologists, European Association for the Study of Diabetes,
(π.χ. American Heart Association, European Society of Cardiology).
7. Hunt SA et al. American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC/ AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009 Apr 14;53(15):e1-e90. doi: 10.1016/j.jacc.2008.11.013.
8. Marx N et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44(39):4043-4140.
9. Kittleson M et al. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May, 81 (18) 1835–1878.
10. Christoph Wanner et al. for the EMPA-REG OUTCOME Investigators, N Engl J Med 2016; 375:323-334
11. Neal B et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644-657.
12. Neal B et al. Optimizing the analysis strategy for the CANVAS program: a prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials. Diabetes Obes Metab. 2017;19(7):926935.
13. Wiviott SD et al. DECLARE–TIMI 58 Investigators. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019 Jan 24;380(4):347-357.
14. McMurray JJV et al.; DAPA-HF Trial Committees and Investigators. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 2019;381:1995–2008
15. Solomon SD et al.; DELIVER Trial Committees and Investigators. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med 2022;387:1089–1098
1. Van Deursen VM et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 2014 Jan;16(1):103-11.
2. William B et al. Role of diabetes in congestive heart failure: The Framingham study, The American Journal of Cardiology, Volume 34, Issue 1, 1974, Pages 29-34
3. Anoop Dinesh Shah et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people, Lancet Diabetes Endocrinol, 2015; 3: 105–113
4. Arnold SV et al. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR). Am Heart J. 2018 Sep;203:2529
5. Owan TE et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006 Jul 20;355(3):2519.
6. McDonagh TA et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/ eurheartj/ehab368
16. Packer M et al.; EMPEROR-Reduced Trial Investigators. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med 2020;383:1413–1424
17. Anker SD et al. EMPEROR-Preserved Trial Investigators. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021 Oct 14;385(16):1451-1461.
18. Standards of Care in Diabetes - 2024, American Diabetes Association, Diabetes Care December 2023, Vol.47
19. Buse JB et al. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020 Feb;43(2):487-493.
20. Ελληνική
21. TA McDonagh et al. ESC Scientific Document Group , 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, Volume 44, Issue 37, 1 October 2023, Pages 3627–3639
(VWF, CRP, OXT, IL-6, ALP, ACE, CXCL10, TNF, DPP-4, CXCL8) -
N.Covid
(IL-6, F3, IL-10, ICAM1, TNF, IFNG, VFGFA, IL-18, CCL-2, NPPB, HMGB1, IL-17A, TGFB1, VCAM1, TLNE14, SER, ACE, TNNT2, CRP) -
= CRP, TNF,
mg/dL (3,5 mmol/L έως 7,8 mmol/L).
✓ TIR >70 % (δηλαδή, >16 ώρες και 48 λεπτά)
✓ TAR <25 % (δηλαδή, <6 ώρες)
✓ TBR <4 % (δηλαδή, <1 ώρα) με <1 % του χρόνου <54 mg/ dL (<14 λεπτά) Οι στόχοι
•
•
•
•
Pajvani.
(Πηγή: all4diabetes.gr, ΕΚΠΑ)
medicaldaily.com, onmed.gr)
oloygeia.gr)
1.
(Πηγή: oloygeia.gr)
•
•
•
(Πηγή: cnet.com, newsbeast.gr)
• 2 φιλέτα γαλοπούλα
• 100 ml ελαιόλαδο
• 700 γρ. σπανάκι καθαρισμένο
• 1 ματσάκι
• 1 ματσάκι
•
•
1,4 gr
3,8 gr
6,9 gr
•
• 250 γρ. γάλα
• 1 αυγό
• 80 γρ. ζάχαρη
• 60 γρ. σπορέλαιο
• 15 γρ.
•
•
•
•
•
•
Dina’s Bakery my best recipes
